Hans Wildiers is a medical oncologist dedicated to breast cancer research and geriatric oncology. His current research focuses on new drug development in breast cancer (with focus on the older population), implementation of geriatric assessment in routine oncology clinic, and translational work on ageing and cancer including biomarkers of ageing.
Hans Wildiers is staff member at the department of medical oncology in the University Hospitals Leuven, Belgium since 2004 as well as halftime senior clinical investigator of Research Fund - Flanders (FWO). He has been active within SIOG - International Society of Geriatric Oncology, since early 2000 and is currently its Executive Board Member.
Hans Wildiers provides expert advice as Board Member of the Geriatric Expert Group (GEG) of the EMA (European Medicine Agency) since 2011. He was also chairman of the Cancer in Elderly Task Force of the European Organisation of Research and Treatment of Cancer (EORTC) from 2009 till 2015.
Hans Wildiers is married and has 4 children.
PRINT THIS PAGE
Page last modified: